138 related articles for article (PubMed ID: 28052399)
1. Molecular trail for the anticancer behavior of a novel copper carbohydrazone complex in BRCA1 mutated breast cancer.
Nair RS; Potti ME; Thankappan R; Chandrika SK; Kurup MR; Srinivas P
Mol Carcinog; 2017 May; 56(5):1501-1514. PubMed ID: 28052399
[TBL] [Abstract][Full Text] [Related]
2. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
3. Structure activity relationship of plumbagin in BRCA1 related cancer cells.
K A T; T R; G R; K C S; Nair RS; G S; Banerji A; Somasundaram V; Srinivas P
Mol Carcinog; 2013 May; 52(5):392-403. PubMed ID: 22290577
[TBL] [Abstract][Full Text] [Related]
4. Differential Cytotoxicity, Cellular Uptake, Apoptosis and Inhibition of BRCA1 Expression of BRCA1-Defective and Sporadic Breast Cancer Cells Induced by an Anticancer Ruthenium(II)-Arene Compound, RAPTA-EA1.
Ratanaphan A; Nhukeaw T; Hongthong K; Dyson PJ
Anticancer Agents Med Chem; 2017; 17(2):212-220. PubMed ID: 27039925
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity of BRCA defective triple negative breast tumors to plumbagin through induction of DNA Double Strand Breaks (DSB).
Nair RS; Kumar JM; Jose J; Somasundaram V; Hemalatha SK; Sengodan SK; Nadhan R; Anilkumar TV; Srinivas P
Sci Rep; 2016 May; 6():26631. PubMed ID: 27220670
[TBL] [Abstract][Full Text] [Related]
6. Cellular responses of BRCA1-defective HCC1937 breast cancer cells induced by the antimetastasis ruthenium(II) arene compound RAPTA-T.
Nhukeaw T; Hongthong K; Dyson PJ; Ratanaphan A
Apoptosis; 2019 Aug; 24(7-8):612-622. PubMed ID: 31016421
[TBL] [Abstract][Full Text] [Related]
7. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
[TBL] [Abstract][Full Text] [Related]
8. The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.
Chen MC; Zhou B; Zhang K; Yuan YC; Un F; Hu S; Chou CM; Chen CH; Wu J; Wang Y; Liu X; Smith DL; Li H; Liu Z; Warden CD; Su L; Malkas LH; Chung YM; Hu MC; Yen Y
Mol Pharmacol; 2015 Jun; 87(6):996-1005. PubMed ID: 25814515
[TBL] [Abstract][Full Text] [Related]
9. Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo.
Tassone P; Di Martino MT; Ventura M; Pietragalla A; Cucinotto I; Calimeri T; Bulotta A; Neri P; Caraglia M; Tagliaferri P
Cancer Biol Ther; 2009 Apr; 8(7):648-53. PubMed ID: 19333003
[TBL] [Abstract][Full Text] [Related]
10. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
Tabassum S; Zaki M; Afzal M; Arjmand F
Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526
[TBL] [Abstract][Full Text] [Related]
11. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of metal complexes of new isatin hydrazones against HCT116, MCF7 and HELA tumour cell lines.
Kandile NG; Mohamed MI; Ismaeel HM
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):330-8. PubMed ID: 21699460
[TBL] [Abstract][Full Text] [Related]
13. Fluorescein hydrazones: A series of novel non-intercalative topoisomerase IIα catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells.
Islam MS; Park S; Song C; Kadi AA; Kwon Y; Rahman AF
Eur J Med Chem; 2017 Jan; 125():49-67. PubMed ID: 27654394
[TBL] [Abstract][Full Text] [Related]
14. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
15. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
16. In vitro platination of human breast cancer suppressor gene1 (BRCA1) by the anticancer drug carboplatin.
Ratanaphan A; Canyuk B; Wasiksiri S; Mahasawat P
Biochim Biophys Acta; 2005 Sep; 1725(2):145-51. PubMed ID: 16099593
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents.
Tassone P; Blotta S; Palmieri C; Masciari S; Quaresima B; Montagna M; D'Andrea E; Eramo OP; Migale L; Costanzo F; Tagliaferri P; Venuta S
Int J Oncol; 2005 May; 26(5):1257-63. PubMed ID: 15809716
[TBL] [Abstract][Full Text] [Related]
18. Salicylate •Phenanthroline copper (II) complex induces apoptosis in triple-negative breast cancer cells.
Fan L; Tian M; Liu Y; Deng Y; Liao Z; Xu J
Oncotarget; 2017 May; 8(18):29823-29832. PubMed ID: 28415735
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantoyl hydrazone bearing pyridine rings.
Rodić MV; Leovac VM; Jovanović LS; Spasojević V; Joksović MD; Stanojković T; Matić IZ; Vojinović-Ješić LS; Marković V
Eur J Med Chem; 2016 Jun; 115():75-81. PubMed ID: 27084495
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor studies on novel Co(II), Ni(II) and Cu(II) metal complexes of bis(3-acetylcoumarin)thiocarbohydrazone.
Sathisha MP; Shetti UN; Revankar VK; Pai KS
Eur J Med Chem; 2008 Nov; 43(11):2338-46. PubMed ID: 18023933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
